Keybank National Association OH cut its holdings in Colgate-Palmolive Company (NYSE:CL – Free Report) by 1.6% during the 3rd quarter, Holdings Channel reports. The fund owned 395,274 shares of the company’s stock after selling 6,493 shares during the period. Keybank National Association OH’s holdings in Colgate-Palmolive were worth $31,598,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors have also recently made changes to their positions in CL. Asset Management One Co. Ltd. increased its stake in shares of Colgate-Palmolive by 3.9% in the third quarter. Asset Management One Co. Ltd. now owns 422,292 shares of the company’s stock worth $33,758,000 after purchasing an additional 16,017 shares in the last quarter. Cidel Asset Management Inc. grew its position in shares of Colgate-Palmolive by 13.6% during the second quarter. Cidel Asset Management Inc. now owns 329,060 shares of the company’s stock valued at $29,912,000 after purchasing an additional 39,413 shares in the last quarter. Vanguard Group Inc. grew its holdings in Colgate-Palmolive by 1.2% during the 2nd quarter. Vanguard Group Inc. now owns 82,751,689 shares of the company’s stock valued at $7,522,129,000 after buying an additional 993,432 shares in the last quarter. Sequoia Financial Advisors LLC grew its holdings in shares of Colgate-Palmolive by 18.6% in the second quarter. Sequoia Financial Advisors LLC now owns 30,273 shares of the company’s stock valued at $2,752,000 after purchasing an additional 4,738 shares in the last quarter. Finally, Exchange Traded Concepts LLC increased its holdings in shares of Colgate-Palmolive by 15.0% in the 3rd quarter. Exchange Traded Concepts LLC now owns 400,137 shares of the company’s stock worth $31,987,000 after buying an additional 52,261 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.
Trending Headlines about Colgate-Palmolive
Here are the key news stories impacting Colgate-Palmolive this week:
- Positive Sentiment: Q4 results beat Street estimates — EPS of $0.95 vs. $0.91 expected and revenue above consensus; management cited strong pricing and brand leadership as drivers of performance. Colgate Q4 Earnings Top Estimates, Strong Pricing Drives Results
- Positive Sentiment: Management issued FY?2026 revenue guidance that’s above consensus (guidance range provided), signaling confidence in sustained demand for essentials across key regions — a primary catalyst for the stock rally. Colgate-Palmolive forecasts upbeat annual sales as essentials spending holds firm
- Positive Sentiment: Core categories showed resilience — oral care and pet nutrition strength plus a Latin America rebound helped sales growth; Market commentary highlights this operating improvement as a near-term positive for margins and top-line momentum. Colgate-Palmolive’s Core Strength Lifts Q4 Results
- Positive Sentiment: Strong cash generation and shareholder returns: record operating cash flow and ~$2.9B returned to shareholders in the year — supports buyback/dividend expectations and investor confidence. Colgate-Palmolive Company Announces 4th Quarter and Full Year 2025 Results
- Neutral Sentiment: Analysts and models are being updated after the print — some price?target revisions were posted ahead/after the call; watch analyst notes for guidance sensitivity and margin assumptions. Colgate-Palmolive Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
- Negative Sentiment: Company recorded a large goodwill/intangible impairment tied to its skin?health business that drove a GAAP loss for the quarter — this one?time charge reduced headline EPS and highlights ongoing challenges in that segment. Colgate-Palmolive Swings to a Loss on Charges
- Negative Sentiment: Softer trends in China and margin pressure in parts of the portfolio were noted on the call — a reminder the recovery is uneven and could limit upside if those regions don’t stabilize. Colgate-Palmolive’s Core Strength Lifts Q4 Results
Analyst Upgrades and Downgrades
Check Out Our Latest Research Report on CL
Colgate-Palmolive Stock Performance
NYSE CL opened at $90.28 on Friday. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $100.18. The company has a debt-to-equity ratio of 5.90, a current ratio of 0.93 and a quick ratio of 0.60. The stock’s 50 day simple moving average is $80.77 and its 200-day simple moving average is $81.38. The company has a market cap of $72.77 billion, a PE ratio of 25.29, a price-to-earnings-growth ratio of 5.74 and a beta of 0.30.
Colgate-Palmolive (NYSE:CL – Get Free Report) last released its earnings results on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a net margin of 14.47% and a return on equity of 333.39%. The business had revenue of $5.23 billion for the quarter, compared to analyst estimates of $5.13 billion. During the same period last year, the company posted $0.91 EPS. The business’s revenue was up 5.8% on a year-over-year basis. As a group, equities research analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.
Colgate-Palmolive Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st will be issued a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.3%. The ex-dividend date is Wednesday, January 21st. Colgate-Palmolive’s payout ratio is presently 58.26%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Read More
- Five stocks we like better than Colgate-Palmolive
- Stock market legend warns: “An Ominous Day Is Coming for the Markets…”
- Another reason you need to own gold… [running out]
- Trump’s Final Shocking Act Begins February 24
- NEW: Gold makes history
- Deutsche Bank Just Raised Their Gold Target to $6,000
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
